Terns Pharmaceuticals Inc (TERN) — Net Asset Quality Index
Terns Pharmaceuticals Inc (TERN) has a Net Asset Quality Index of 94.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $301.65 Million minus total liabilities of $17.59 Million yields net assets of $284.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. See TERN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Terns Pharmaceuticals Inc Net Asset Quality Index Over Time (2018–2024)
This chart shows how Terns Pharmaceuticals Inc's Net Asset Quality Index has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the index stands at 94.2%, representing net assets of $284.07 Million against total assets of $301.65 Million USD. Explore cash flow conversion of Terns Pharmaceuticals Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Terns Pharmaceuticals Inc (2018–2024)
The table below presents the year-by-year Net Asset Quality Index for Terns Pharmaceuticals Inc from 2018 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Terns Pharmaceuticals Inc (TERN) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.0% | $345.87 Million | $363.93 Million | $18.06 Million | ▼ -0.1 pp |
| 2023 | 95.1% | $255.37 Million | $268.52 Million | $13.15 Million | ▼ -1.4 pp |
| 2022 | 96.5% | $276.94 Million | $287.03 Million | $10.08 Million | ▲ +1.1 pp |
| 2021 | 95.4% | $160.30 Million | $168.07 Million | $7.77 Million | ▲ +21.1 pp |
| 2020 | 74.3% | $68.59 Million | $92.29 Million | $23.70 Million | ▼ -2.3 pp |
| 2019 | 76.7% | $18.32 Million | $23.90 Million | $5.58 Million | ▼ -4.4 pp |
| 2018 | 81.1% | $72.23 Million | $89.07 Million | $16.84 Million | — |